Related Experiment Video
Updated: Sep 22, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Semiautomated Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Observational Study in
Jean-Michel Liet1, Julien Baleine2, Pierre Demaret3
1Division of Pediatric Critical Care Medicine, Department of Neonatal Medicine and Pediatric Intensive Care, University Hospital of Nantes, Nantes, France.
Insights
Semiautomated regional citrate anticoagulation (saRCA) is feasible for continuous kidney replacement therapy (CKRT) in children under 11 kg. Strict protocols and training are essential to manage complications like citrate intoxication.
Area of Science:
- Pediatric Nephrology
- Critical Care Medicine
- Renal Replacement Therapy
Background:
- Continuous kidney replacement therapy (CKRT) is vital for critically ill children with kidney failure.
- Regional citrate anticoagulation (RCA) is an alternative to systemic heparinization, potentially reducing bleeding complications.
- Semiautomated RCA (saRCA) offers a more standardized approach to citrate anticoagulation during CKRT.
Purpose of the Study:
- To review the utilization and outcomes of saRCA for CKRT in young children weighing less than 11 kg.
- To identify the incidence of citrate intoxication and unscheduled interruptions during saRCA in this pediatric population.
Main Methods:
- Retrospective cohort study conducted across three pediatric intensive care units (PICUs).
- Analysis of data from consecutive children weighing less than 11 kg who received CKRT with saRCA between January 2015 and June 2020.
- Evaluation of CKRT session duration, number of sessions, citrate intoxication events, and unscheduled interruptions.
Main Results:
- Twenty-one children weighing less than 11 kg underwent CKRT with saRCA, totaling 2,014 hours across 64 sessions.
- Citrate intoxication occurred in 6% of sessions (4/64), specifically when initial lactate was >4 mmol/L or replacement fluid to citrate flow ratio was <50%.
- The rate of unscheduled CKRT interruptions was 25% (16/64).
Conclusions:
- Semiautomated regional citrate anticoagulation can be utilized for CKRT in neonates and young children weighing less than 11 kg.
- Implementation requires a strict protocol and intensive staff training to minimize the risk of citrate intoxication and other complications.
- Careful monitoring of lactate levels and fluid flow ratios is crucial for safe saRCA use in this vulnerable population.
Objectives:
To review use of semiautomated regional citrate anticoagulation (saRCA) for continuous kidney replacement therapy (CKRT) in young children.
Design:
Retrospective cohort study.
Setting:
Three independent PICUs.
Patients:
All consecutive children weighing less than 11 kg who received CKRT with saRCA from January 2015 to June 2020.
Interventions:
None.
Measurements And Main Results:
Twenty-one children weighing less than 11 kg underwent CKRT with saRCA. The total duration of the CKRT was 2,014 hours, with a total of 64 CKRT sessions. Citrate intoxication occurred in four of 64 CKRT sessions (6%). Citrate intoxication was consistently observed in the few CKRT sessions where the initial lactate concentration was greater than 4 mmol/L or the ratio of replacement fluid flow to citrate flow less than 50%. The rate of unscheduled interruptions of CKRT sessions was 25% (16/64).
Conclusions:
We have used saRCA for CKRT in children weighing less than 11 kg. A strict protocol and intensive training are required to minimize complications.
Related Concept Videos
Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease III: Interprofessional Care

